LONDON--(BUSINESS WIRE)--Intelligent Fingerprinting has announced that its saliva-based COVID-19 test now carries CE marking and is available for sale. The new VSS-GP COVID-19 Saliva Test uses a ...
Intelligent Bio Solutions Inc. (NASDAQ:INBS) on Wednesday announced that Managed Waste Service plans to implement INBS' Intelligent Fingerprinting Drug Screening System across its New South Wales ...
NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...
Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced on Wednesday that it received a patent in the United States relating to its Intelligent Fingerprinting Drug Screening Cartridge. This is the ...
Intelligent Bio Solutions Secures UK Patent for Intelligent Fingerprinting DSR-Plus Cartridge Reader
NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...
Study designed to validate accuracy and real-world workplace performance of the Intelligent Fingerprinting Drug Screening System Company expects to complete enrollment and data collection by the end ...
Intelligent Fingerprinting has developed a revolutionary new fingerprint drug test, the first of its kind in the world. The portable, non-invasive, fingerprint-based Drug Screening System works by ...
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results